Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE LAZARE CARNOT : revenue, balance sheet and financial ratios

GRANDE PHARMACIE LAZARE CARNOT is a French company founded 17 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TOULON (83000), this company of category PME shows in 2025 a net income positive of 164 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE LAZARE CARNOT (SIREN 509107165)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 164 477 € 131 475 € 72 595 € 546 667 € 316 907 € 65 077 € 57 030 € 41 068 € -87 862 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, GRANDE PHARMACIE LAZARE CARNOT generates positive net income of 164 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

164 477 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 192%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

192.331%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

26.147%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

12.7%

Solvency indicators evolution
GRANDE PHARMACIE LAZARE CARNOT

Sector positioning

Debt ratio
192.33 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

In 2025, the debt ratio of GRANDE PHARMACIE LAZARE C... (192.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
26.15% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

In 2025, the financial autonomy of GRANDE PHARMACIE LAZARE C... (26.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 220.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

220.682

Liquidity indicators evolution
GRANDE PHARMACIE LAZARE CARNOT

Sector positioning

Liquidity ratio
220.68 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good +7 pts over 3 years

In 2025, the liquidity ratio of GRANDE PHARMACIE LAZARE C... (220.68) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of GRANDE PHARMACIE LAZARE CARNOT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of GRANDE PHARMACIE LAZARE CARNOT is estimated at 2 612 736 € (range 1 773 015€ - 4 099 743€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
1773k€ 2612k€ 4099k€
2 612 736 € Range: 1 773 015€ - 4 099 743€
NAF 5 année 2025

Valuation method used

Net Income Multiple
164 477 € × 15.9x = 2 612 737 €
Range: 1 773 015€ - 4 099 744€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE LAZARE CARNOT with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE LAZARE CARNOT

What is the revenue of GRANDE PHARMACIE LAZARE CARNOT ?

The revenue of GRANDE PHARMACIE LAZARE CARNOT is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE LAZARE CARNOT profitable?

Yes, GRANDE PHARMACIE LAZARE CARNOT generated a net profit of 164 k€ in 2025.

Where is the headquarters of GRANDE PHARMACIE LAZARE CARNOT ?

The headquarters of GRANDE PHARMACIE LAZARE CARNOT is located in TOULON (83000), in the department Var.

Where to find the tax return of GRANDE PHARMACIE LAZARE CARNOT ?

The tax return of GRANDE PHARMACIE LAZARE CARNOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE LAZARE CARNOT operate?

GRANDE PHARMACIE LAZARE CARNOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.